These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17539195)

  • 21. Simultaneous demonstration of metabolic lesions consistent with Alzheimer disease and brain metastases on FDG-PET imaging.
    Takalkar AM; El-Haddad G; Lilien DL; Patterson JC
    Clin Nucl Med; 2008 Jun; 33(6):438-40. PubMed ID: 18496460
    [No Abstract]   [Full Text] [Related]  

  • 22. Determinations of cerebral glucose utilization in dementia using positron emission tomography.
    Kuhl DE; Metter EJ; Riege WH; Hawkins RA
    Dan Med Bull; 1985 Feb; 32 Suppl 1():51-5. PubMed ID: 3872772
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuroimaging for diagnosis of dementia.
    Small GW; Leiter F
    J Clin Psychiatry; 1998; 59 Suppl 11():4-7. PubMed ID: 9731543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
    Farkas T; Ferris SH; Wolf AP; De Leon MJ; Christman DR; Reisberg B; Alavi A; Fowler JS; George AE; Reivich M
    Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
    [No Abstract]   [Full Text] [Related]  

  • 25. Positron emission tomography scanning for the early diagnosis of dementia.
    Small GW
    West J Med; 1999; 171(5-6):293-4. PubMed ID: 10639858
    [No Abstract]   [Full Text] [Related]  

  • 26. Computerized tomography: A recent advance in evaluating senile dementia.
    Fox JH; Huckman MS
    Geriatrics; 1975 Nov; 30(11):97-100. PubMed ID: 1102396
    [No Abstract]   [Full Text] [Related]  

  • 27. [Single-photon emission-computed tomography in the differential diagnosis of dementia].
    Deisenhammer E; Reisecker F; Leblhuber F; Höll K; Markut H; Trenkler J; Schneider I
    Dtsch Med Wochenschr; 1989 Oct; 114(43):1639-44. PubMed ID: 2530079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial positron emission tomography findings in a patient with hydrocephalic dementia and Alzheimer's disease.
    Jeong Y; Chin J; Tae WS; Hong SB; Kim SE; Suh YL; Na DL
    J Neuroimaging; 2004 Apr; 14(2):170-5. PubMed ID: 15095564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography in dementia of the Alzheimer type. A brief review with a case study.
    Berg G; Grady CL; Sundaram M; Haxby JV; Moore AM; White J; Heston L; Rapoport SI; Avioli LV
    Arch Intern Med; 1986 Oct; 146(10):2045-9. PubMed ID: 3490239
    [No Abstract]   [Full Text] [Related]  

  • 31. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
    Foster NL; Heidebrink JL; Clark CM; Jagust WJ; Arnold SE; Barbas NR; DeCarli CS; Turner RS; Koeppe RA; Higdon R; Minoshima S
    Brain; 2007 Oct; 130(Pt 10):2616-35. PubMed ID: 17704526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomographic study in Alzheimer's disease and Pick's disease.
    Salmon E; Franck G
    Arch Gerontol Geriatr Suppl; 1989; 1():241-7. PubMed ID: 2787995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of demented patients by dynamic SPECT of inhaled xenon-133.
    Komatani A; Yamaguchi K; Sugai Y; Takanashi T; Kera M; Shinohara M; Kawakatsu S
    J Nucl Med; 1988 Oct; 29(10):1621-6. PubMed ID: 3262723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Computer tomography contribution to the differential diagnosis of dementia of vascular origin (multi-infarction type) and primary degenerative dementia (Alzheimer type)].
    Kohlmeyer K
    Z Gerontol; 1982; 15(6):321-4. PubMed ID: 7168233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease.
    de Leon MJ; Ferris SH; George AE; Reisberg B; Christman DR; Kricheff II; Wolf AP
    J Cereb Blood Flow Metab; 1983 Sep; 3(3):391-4. PubMed ID: 6603463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid burden in diabetes-related dementia.
    Takenoshita N; Shimizu S; Fukasawa R; Sato T; Kanetaka H; Sakurai H; Ishii K; Hanyu H
    Geriatr Gerontol Int; 2019 Oct; 19(10):1066-1068. PubMed ID: 31602757
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the contribution of the importance of neuroimaging in dementia--comparison with the psychological diagnosis].
    Krampla W
    Rofo; 2004 Mar; 176(3):426; discussion 426-7. PubMed ID: 15077614
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of 99Tcm-HM-PAO for the diagnosis of dementia.
    Smith FW; Gemmell HG; Sharp PF
    Nucl Med Commun; 1987 Jul; 8(7):525-33. PubMed ID: 2960922
    [No Abstract]   [Full Text] [Related]  

  • 39. Topographic patterns of brain functional impairment progression according to clinical severity staging in 116 Alzheimer disease patients: FDG-PET study.
    Choo IH; Lee DY; Youn JC; Jhoo JH; Kim KW; Lee DS; Lee JS; Woo JI
    Alzheimer Dis Assoc Disord; 2007; 21(2):77-84. PubMed ID: 17545731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered patterns of positron-emission tomography glucose metabolism in Alzheimer patients with microvascular white matter disease.
    De Leon MJ; George AE; Miller JD; Ferris SH; Klinger AJ; Franssen E; Kluger A; Sachs H; Gianutsos JG; La Regina ME
    Am J Physiol Imaging; 1988; 3(1):52-3. PubMed ID: 3260505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.